Skip to main content

Swedbank AB

Bank

Position in HALO — Halozyme Therapeutics, Inc.

CIK 946431 STOCKHOLM, V7

Position in HALO

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$15,842,786
+$5,455,970 QoQ
Shares Held
202,412
+25.9% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 70 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. HALO ranks #10 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,842,786 202,412
2026-03-31 $10,386,816 160,712
2025-12-31 $10,906,772 162,062
2025-09-30 $10,792,861 147,162
2025-06-30 $8,175,567 157,162
2024-12-31 $13,547,537 283,362
2024-09-30 $18,223,040 318,362
2024-06-30 $17,402,474 332,362
2024-03-31 $13,927,286 342,362
2023-12-31 $15,351,779 415,362
2023-09-30 $15,503,928 405,862
2023-06-30 $15,887,464 440,462
2023-03-31 $16,821,243 440,462
2022-12-31 $35,835,278 629,794
2022-09-30 $25,297,454 639,794
2022-06-30 $54,568,536 1,240,194
2022-03-31 $80,058,860 2,007,494
2021-12-31 $73,182,200 1,820,000
2021-09-30 $60,538,430 1,488,162
2021-06-30 $44,047,700 970,000
2021-03-31 $35,307,552 846,907